Award,contract · Find a Tender
NP94023a-d Ellipta Inhalers
Part of NP94023a-d Ellipta Inhalers.
Supply of Ellipta Inhalers to NHS Scotland: NP94023a: Umeclidinium bromide 65micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Anoro® Ellipta®) NP94023b: Umeclidinium bromide 65micrograms/dose dry powder inhaler (Incruse® Ellipta®) NP94023c: Fluticasone furoate 184micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Relvar® Ellipta®) NP94023c: Fluticasone furoate 92micrograms/dose / Vilanterol 22micrograms/dose dry powder inhaler (Relvar® Ellipta®) NP94023d: Fluticasone furoate 92micrograms/dose / Umeclidinium 55micrograms/dose / Vilanterol 22micrograms/dose dry…
- Procurement
- NP94023a-d Ellipta Inhalers
- Published
- 28 Jul 2023
- Status
- complete
- CPV
- 33600000 — Pharmaceutical products
- Tender period
- —
Awards
Other notices in this procurement
FAQs about this notice
What type of notice is this?
This is a award,contract published via Find a Tender on 28 Jul 2023.
Which procurement does this notice belong to?
It is part of "NP94023a-d Ellipta Inhalers", published by The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS").
Has this notice resulted in an award?
1 award is recorded on this notice, including to GSK UK Limited.
Get the full procurement picture
Enable turns the UK's public-contract data into pipeline intelligence for bid and capture teams. Talk to us about access, alerts and tailored market analysis.
Get in touch with Enable